This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Methylphenidate: Difference between revisions
>David Hedlund An example of an extended-release formula includes the methylphenidate medication brand Concerta. |
>David Hedlund unlink methylphenidate |
||
| Line 144: | Line 144: | ||
In vitro data suggest that some extended-release stimulants may experience dose dumping in the presence of alcohol. This is a concern because the ADHD patient population is at risk for alcohol abuse. The potential for dose dumping when taking extended-release stimulants with alcohol could lead to unintended and dangerous side effects for those with ADHD.<ref>{{cite journal |last1=Jain |first1=R |last2=Stark |first2=JG |title=Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications. |journal=Postgraduate medicine |date=September 2016 |volume=128 |issue=7 |pages=672-81 |doi=10.1080/00325481.2016.1218259 |pmid=27467139}}</ref> | In vitro data suggest that some extended-release stimulants may experience dose dumping in the presence of alcohol. This is a concern because the ADHD patient population is at risk for alcohol abuse. The potential for dose dumping when taking extended-release stimulants with alcohol could lead to unintended and dangerous side effects for those with ADHD.<ref>{{cite journal |last1=Jain |first1=R |last2=Stark |first2=JG |title=Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications. |journal=Postgraduate medicine |date=September 2016 |volume=128 |issue=7 |pages=672-81 |doi=10.1080/00325481.2016.1218259 |pmid=27467139}}</ref> | ||
An example of an extended-release formula includes the | An example of an extended-release formula includes the methylphenidate medication brand Concerta. | ||
===Dangerous interactions=== | ===Dangerous interactions=== | ||